Haemophilus Influenzae Type Disease
📧 Sign up to get email alerts when something new happens for Haemophilus Influenzae Type Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-07EMA Authorised: Hexacima (hepatitis B surface antigen;Diphtheria toxoid;Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin;poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett);Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) conjugated to Tetanus protein;tetanus toxoid) — Sanofi Winthrop Industrie
EMA authorised Hexacima, a combination vaccine covering hepatitis B, diphtheria, pertussis, poliomyelitis, Haemophilus influenzae type b, te…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series [Phase 2, Phase 3]
Phase II/III trial update evaluating the immunogenicity, safety, and lot-to-lot consistency of LBVD, a fully liquid hexavalent DTaP-HepB-IPV…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) [Phase 3]
Phase 3 trial evaluating a pentavalent DTP-HB-Hib vaccine for immunogenicity and safety has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Hepatitis B Vaccination in Infants [Phase 4]
A Phase 4 clinical trial update on Hepatitis B vaccination in infants has completed, with sponsor Public Health England evaluating vaccinati…
-
FDA approval · 2020-09-02FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's supplemental application for rifampin (RIFAMPIN).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a booster dose of Infanrix Hexa in healthy infants born to mothers vaccinated with Boo…
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m [Phase 3]
Phase 3 trial update of Tritanrix-HepB/Hib-MenAC and Mencevax ACWY vaccines with completed status and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine [Phase 4]
Phase 4 clinical trial assessing immediate and long-term immune responses to a Hib booster dose in infants and young children.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 trial assessing immunogenicity and safety of GSK Infanrix Hexa given at 2, 4, and 6 months in healthy infants; study completed wit…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age [Phase 3]
Phase 3 immunogenicity and safety study comparing Hib-MenCY-TT (MenHibrix) to PedvaxHIB in healthy infants and toddlers; study completed wit…
-
CLINICAL_TRIALS withdrawal · 2017-12-26Clinical Trial Update: Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Infanrix-IPV/Hib (DTPa-IPV/Hib) in healthy Indian infants has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths [Phase 2]
Phase 2 trial evaluating immune response and safety of a DTPw-HBV/Hib booster vaccine given at 15-18 months; study completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine [Phase 4]
This Phase 4 clinical trial evaluated the safety and reactogenicity of GlaxoSmithKline's Hib (Haemophilus influenzae type b) vaccine when ad…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers [Phase 2]
Phase 2 trial assessing immunogenicity and reactogenicity of a booster dose of GSK2036874A vaccine in healthy toddlers; study completed with…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) [Phase 3]
Phase 3 safety study of GSK's DTPa-IPV/Hib vaccine (Infanrix-IPV/Hib) has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children [Phase 3]
Phase 3 safety study results completed for combination vaccines Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY in child…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants [Phase 3]
Phase 3 clinical trial update assessing immune memory and reactogenicity of the DTPw-HBV/Hib pentavalent vaccine in infants, including respo…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ [Phase 4]
Phase 4 study assessing antibody persistence in children previously vaccinated with Infanrix Hexa or Infanrix-IPV/Hib; completed with result…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 trial update evaluating the immunogenicity and safety of a pentavalent DTPa-HBV-IPV/Hib vaccine given at 2, 3, and 4 months of age.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. [Phase 3]
A Phase 3 immunization and safety study comparing two formulations of DTPw-HBV/HIB given at birth with Hepatitis B at 2, 4, and 6 months was…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of GlaxoSmithKline's pentavalent DTPa-HBV-IPV/Hib vaccine in Indian infants across two va…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib [Phase 3]
Phase 3 booster study evaluating immunogenicity, reactogenicity, and safety of GSK's DTPw-HBV/Hib vaccine booster compared with the standard…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 [Phase 2]
Phase 2 clinical trial update evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine and a single dose of t…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197 [Phase 3]
Phase 3 safety, reactogenicity and immunogenicity study evaluating a booster dose of Hib-MenC given with Priorix in toddlers previously prim…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth [Phase 3]
This Phase 3 trial evaluated and compared the immune responses to two DTP-containing vaccines (Tritanrix-HepB/Hib-MenAC vs Tritanrix-HepB/Hi…